The plasma membrane metal-ion transporter ZIP14 contributes to nontransferrin-bound iron uptake by human β-cells

American Journal of Physiology - Cell Physiology

Volumn 312, Issue 2, 2017, Pages C169-C175

  Coffey, Richard ^a   Knutson, Mitchell D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Diabetes; Hemochromatosis; Iron; ZIP14; cell

Indexed keywords

IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZIP14 PROTEIN; ZIP8 PROTEIN; CATION TRANSPORT PROTEIN; DMRT1 PROTEIN; SLC39A14 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSFERRIN; ZIP8 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IRON OVERLOAD; IRON TRANSPORT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; CELL CULTURE; CELL LINE; CELL MEMBRANE; CHANNEL GATING; METABOLISM; PHYSIOLOGY;

CATION TRANSPORT PROTEINS; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; HUMANS; INSULIN-SECRETING CELLS; ION CHANNEL GATING; IRON; TRANSCRIPTION FACTORS; TRANSFERRIN;

EID: 85012037096     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00116.2016     Document Type: Article

References (44)

1. Altamura S, Kessler R, Gröne HJ, Gretz N, Hentze MW, Galy B, Muckenthaler MU. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload. Cell Metab 20: 359–367, 2014. doi:10.1016/j.cmet.2014.07.007.
2. Bradbury MW, Raja K, Ueda F. Contrasting uptakes of 59Fe into spleen, liver, kidney and some other soft tissues in normal and hypotransferrinaemic mice. Influence of an antibody against the transferrin receptor. Biochem Pharmacol 47: 969–974, 1994. doi:10.1016/0006-2952(94)90407-3.
3. Brissot P, Ropert M, Le Lan C, Loréal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 1820: 403–410, 2012. doi:10.1016/j.bbagen.2011.07.014.
4. Casu C, Rivella S. Iron age: novel targets for iron overload. Hematology Am Soc Hematol Educ Program 2014: 216–221, 2014.
5. Coffey R, Nam H, Knutson MD. Microarray analysis of rat pancreas reveals altered expression of Alox15 and regenerating islet-derived genes in response to iron deficiency and overload. PLoS One 9: e86019, 2014. doi:10.1371/journal.pone.0086019.
6. Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, Kaplan J. Tissue distribution and clearance kinetics of non-transferrinbound iron in the hypotransferrinemic mouse: a rodent model for hemo-chromatosis. Proc Natl Acad Sci USA 84: 3457–3461, 1987. doi:10.1073/pnas.84.10.3457.
7. de la Tour D, Halvorsen T, Demeterco C, Tyrberg B, Itkin-Ansari P, Loy M, Yoo SJ, Hao E, Bossie S, Levine F. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 15: 476–483, 2001.
8. El Muayed M, Billings LK, Raja MR, Zhang X, Park PJ, Newman MV, Kaufman DB, O’Halloran TV, Lowe WL Jr. Acute cytokinemediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function. J Endocrinol 206: 159–169, 2010. doi:10.1677/JOE-09-0420.
9. Evans RW, Rafique R, Zarea A, Rapisarda C, Cammack R, Evans PJ, Porter JB, Hider RC. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J Biol Inorg Chem 13: 57–74, 2008. doi:10.1007/s00775-007-0297-8.
10. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 95: 1148–1153, 1998. doi:10.1073/pnas.95.3.1148.
11. Ganz T. Systemic iron homeostasis. Physiol Rev 93: 1721–1741, 2013. doi:10.1152/physrev.00008.2013.
12. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264: 4417–4422, 1989.
13. Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, Andrews NC. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest 115: 1258–1266, 2005. doi:10.1172/JCI24356.
14. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482–488, 1997. doi:10.1038/41343.
15. 2+ channel. J Biol Chem 281: 9361–9372, 2006. doi:10.1074/jbc.M508542200.
16. 2+ in pancreatic alpha-cells. J Biol Chem 283: 10184–10197, 2008. doi:10.1074/jbc.M707005200.
17. Hansen JB, Moen IW, Mandrup-Poulsen T. Iron: the hard player in diabetes pathophysiology. Acta Physiol (Oxf) 210: 717–732, 2014. doi: 10.1111/apha.12256.
18. Horne WI, Tandler B, Dubick MA, Niemelä O, Brittenham GM, Tsukamoto H. Iron overload in the rat pancreas following portacaval shunting and dietary iron supplementation. Exp Mol Pathol 64: 90–102, 1997. doi:10.1006/exmp.1997.2212.
19. Jenkitkasemwong S, Wang CY, Coffey R, Zhang W, Chan A, Biel T, Kim JS, Hojyo S, Fukada T, Knutson MD. SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab 22: 138–150, 2015. doi:10.1016/j.cmet.2015.05.002.
20. Kishimoto M, Endo H, Hagiwara S, Miwa A, Noda M. Immunohistochemical findings in the pancreatic islets of a patient with transfusional iron overload and diabetes: case report. J Med Invest 57: 345–349, 2010. doi:10.2152/jmi.57.345.
21. Knutson MD, Walter PB, Ames BN, Viteri FE. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr 130: 621–628, 2000.
22. Koch RO, Zoller H, Theuri I, Obrist P, Egg G, Strohmayer W, Vogel W, Weiss G. Distribution of DMT 1 within the human glandular system. Histol Histopathol 18: 1095–1101, 2003.
23. Kumfu S, Chattipakorn S, Chinda K, Fucharoen S, Chattipakorn N. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol 88: 535–548, 2012. doi:10.1111/j.1600-0609.2012.01779.x.
24. Le Lan C, Loréal O, Cohen T, Ropert M, Glickstein H, Lainé F, Pouchard M, Deugnier Y, Le Treut A, Breuer W, Cabantchik ZI, Brissot P. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood 105: 4527–4531, 2005. doi:10.1182/blood-2004-09-3468.
25. Lee DH, Liu DY, Jacobs DR Jr., Shin HR, Song K, Lee IK, Kim B, Hider RC. Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care 29: 1090–1095, 2006. doi:10.2337/dc05-2471.
26. Lichten LA, Liuzzi JP, Cousins RJ. Interleukin-1β contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol 296: G860–G867, 2009. doi:10.1152/ajpgi.90676.2008.
27. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci USA 103: 13612–13617, 2006. doi:10.1073/pnas.0606424103.
28. Lu JP, Hayashi K. Selective iron deposition in pancreatic islet B cells of transfusional iron-overloaded autopsy cases. Pathol Int 44: 194–199, 1994. doi:10.1111/j.1440-1827.1994.tb02592.x.
29. Lu JP, Hayashi K, Okada S, Awai M. Transferrin receptors and selective iron deposition in pancreatic B cells of iron-overloaded rats. Acta Pathol Jpn 41: 647–652, 1991.
30. Mackenzie B, Takanaga H, Hubert N, Rolfs A, Hediger MA. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem J 403: 59–69, 2007. doi:10.1042/BJ20061290.
31. McClain DA, Abraham D, Rogers J, Brady R, Gault P, Ajioka R, Kushner JP. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 49: 1661–1669, 2006. doi:10.1007/s00125-006-0200-0.
32. Nam H, Wang CY, Zhang L, Zhang W, Hojyo S, Fukada T, Knutson MD. ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 98: 1049–1057, 2013. doi:10.3324/haematol.2012.072314.
33. Nick H, Allegrini PR, Fozard L, Junker U, Rojkjaer L, Salie R, Niederkofler V, O’Reilly T. Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis. Exp Biol Med (Maywood) 234: 492–503, 2009. doi:10.3181/0811-RM-337.
34. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9: 1187–1194, 2003. doi:10.1038/nm920.
35. Pae EK, Kim G. Insulin production hampered by intermittent hypoxia via impaired zinc homeostasis. PLoS One 9: e90192, 2014. doi:10.1371/journal.pone.0090192.
36. Pelot D, Zhou XJ, Carpenter P, Vaziri ND. Effects of experimental hemosiderosis on pancreatic tissue iron content and structure. Dig Dis Sci 43: 2411–2414, 1998. doi:10.1023/A:1026669829121.
37. Rahier J, Loozen S, Goebbels RM, Abrahem M. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia 30: 5–12, 1987. doi:10.1007/BF01788899.
38. Ramey G, Faye A, Durel B, Viollet B, Vaulont S. Iron overload in Hepc1(-/-) mice is not impairing glucose homeostasis. FEBS Lett 581: 1053–1057, 2007. doi:10.1016/j.febslet.2007.02.002.
39. Simpson RJ, Deenmamode J, McKie AT, Raja KB, Salisbury JR, Iancu TC, Peters TJ. Time-course of iron overload and biochemical, histopathological and ultrastructural evidence of pancreatic damage in hypotransferrinaemic mice. Clin Sci (Lond) 93: 453–462, 1997. doi:10.1042/cs0930453.
40. Walling C, Partch RE, Weil T. Kinetics of the decomposition of hydrogen peroxide catalyzed by ferric ethylenediaminetetraacetate complex. Proc Natl Acad Sci USA 72: 140–142, 1975. doi:10.1073/pnas.72.1.140.
41. Walter PB, Knutson MD, Paler-Martinez A, Lee S, Xu Y, Viteri FE, Ames BN. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci USA 99: 2264–2269, 2002. doi:10.1073/pnas.261708798.
42. Wang CY, Jenkitkasemwong S, Duarte S, Sparkman BK, Shawki A, Mackenzie B, Knutson MD. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J Biol Chem 287: 34032–34043, 2012. doi:10.1074/jbc.M112.367284.
43. Wang CY, Knutson MD. Hepatocyte divalent metal-ion transporter-1 is dispensable for hepatic iron accumulation and non-transferrin-bound iron uptake in mice. Hepatology 58: 788–798, 2013. doi:10.1002/hep.26401.
44. Zhao N, Zhang AS, Worthen C, Knutson MD, Enns CA. An ironregulated and glycosylation-dependent proteasomal degradation pathway for the plasma membrane metal transporter ZIP14. Proc Natl Acad Sci USA 111: 9175–9180, 2014. doi:10.1073/pnas.1405355111.